K. Höffken

7.4k total citations
186 papers, 5.4k citations indexed

About

K. Höffken is a scholar working on Oncology, Molecular Biology and Pulmonary and Respiratory Medicine. According to data from OpenAlex, K. Höffken has authored 186 papers receiving a total of 5.4k indexed citations (citations by other indexed papers that have themselves been cited), including 80 papers in Oncology, 34 papers in Molecular Biology and 34 papers in Pulmonary and Respiratory Medicine. Recurrent topics in K. Höffken's work include Acute Myeloid Leukemia Research (20 papers), Cancer Treatment and Pharmacology (20 papers) and Colorectal Cancer Treatments and Studies (14 papers). K. Höffken is often cited by papers focused on Acute Myeloid Leukemia Research (20 papers), Cancer Treatment and Pharmacology (20 papers) and Colorectal Cancer Treatments and Studies (14 papers). K. Höffken collaborates with scholars based in Germany, France and United States. K. Höffken's co-authors include Ulrich Wedding, R. Kath, Ludger Pientka, Peter Buggisch, Jens Witte, Herbert G. Sayer, Katharina Pachmann, Joachim H. Clement, H. Hirche and R. Pichlmayr and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and Blood.

In The Last Decade

K. Höffken

158 papers receiving 5.2k citations

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
K. Höffken 2.6k 1.1k 967 855 848 186 5.4k
Jon P. Gockerman 1.5k 0.6× 836 0.7× 879 0.9× 1.1k 1.3× 636 0.8× 128 4.4k
Peter F. Coccia 1.5k 0.6× 1.3k 1.1× 1.1k 1.1× 1.7k 2.0× 846 1.0× 108 5.7k
Marek Z. Wojtukiewicz 2.2k 0.8× 1.0k 0.9× 342 0.4× 996 1.2× 809 1.0× 190 4.5k
Donn C. Young 1.8k 0.7× 1.2k 1.1× 872 0.9× 323 0.4× 1.1k 1.3× 137 5.7k
Séamus O’Reilly 3.9k 1.5× 1.4k 1.2× 1.6k 1.7× 419 0.5× 1.2k 1.5× 227 6.8k
Peter C. Huijgens 2.0k 0.8× 1.0k 0.9× 1.2k 1.2× 2.5k 2.9× 729 0.9× 182 6.8k
Gloria Broadwater 3.1k 1.2× 1.2k 1.0× 592 0.6× 530 0.6× 1.0k 1.2× 182 6.2k
James A. Neidhart 1.5k 0.6× 672 0.6× 951 1.0× 356 0.4× 539 0.6× 75 3.5k
Ann T. Farrell 2.5k 1.0× 2.8k 2.5× 632 0.7× 1.6k 1.8× 621 0.7× 75 6.7k
Shouhao Zhou 4.5k 1.8× 1.1k 0.9× 484 0.5× 497 0.6× 1.3k 1.6× 162 7.9k

Countries citing papers authored by K. Höffken

Since Specialization
Citations

This map shows the geographic impact of K. Höffken's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by K. Höffken with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites K. Höffken more than expected).

Fields of papers citing papers by K. Höffken

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by K. Höffken. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by K. Höffken. The network helps show where K. Höffken may publish in the future.

Co-authorship network of co-authors of K. Höffken

This figure shows the co-authorship network connecting the top 25 collaborators of K. Höffken. A scholar is included among the top collaborators of K. Höffken based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with K. Höffken. K. Höffken is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Pachmann, Katharina, Oumar Camara, Andreas Kavallaris, et al.. (2008). Monitoring the Response of Circulating Epithelial Tumor Cells to Adjuvant Chemotherapy in Breast Cancer Allows Detection of Patients at Risk of Early Relapse. Journal of Clinical Oncology. 26(8). 1208–1215. 221 indexed citations
2.
3.
Wedding, Ulrich, Bernd Röhrig, Ludger Pientka, et al.. (2007). Depression and functional impairment independently contribute to decreased quality of life in cancer patients prior to chemotherapy. Acta Oncologica. 47(1). 56–62. 46 indexed citations
4.
Wedding, Ulrich, Bernd Roehrig, Almuth Klippstein, et al.. (2007). Comorbidity in patients with cancer: Prevalence and severity measured by cumulative illness rating scale. Critical Reviews in Oncology/Hematology. 61(3). 269–276. 68 indexed citations
5.
Farker, Katrin, et al.. (2006). Chronomodulated chemotherapy with oxaliplatin, 5-FU and sodium folinate in metastatic gastrointestinal cancer patients: analysis of non-hematological toxicity and patient characteristics in a. International Journal of Clinical Pharmacology and Therapeutics. 44(1). 31–37. 7 indexed citations
6.
7.
Kasper, Christoph, Herbert G. Sayer, Lars‐Olof Mügge, et al.. (2004). Combined standard graft-versus-host disease (GvHD) prophylaxis with mycophenolate mofetil (MMF) in allogeneic peripheral blood stem cell transplantation from unrelated donors. Bone Marrow Transplantation. 33(1). 65–69. 20 indexed citations
8.
Klippstein, Almuth, et al.. (2003). Pneumocystis carinii pneumonia as a complication of bendamustine monotherapy in a patient with advanced progressive breast cancer. Journal of Cancer Research and Clinical Oncology. 129(5). 316–319. 21 indexed citations
9.
Sayer, Herbert G., M. Kröger, J. Beyer, et al.. (2003). Reduced intensity conditioning for allogeneic hematopoietic stem cell transplantation in patients with acute myeloid leukemia: disease status by marrow blasts is the strongest prognostic factor. Bone Marrow Transplantation. 31(12). 1089–1095. 118 indexed citations
10.
Kath, R., et al.. (2002). Zerebrale Metastasen bei kolorektalen Karzinomen. Medizinische Klinik. 97(6). 327–334. 7 indexed citations
11.
12.
Schiel, Ralf, Marcus Blum, Ulrich Müller, et al.. (2001). Screening for people with diabetes mellitus for poor blood glucose control in an ophthalmological laser clinic. Diabetes Research and Clinical Practice. 53(3). 173–179. 3 indexed citations
13.
Kath, R., et al.. (2001). Bendamustin, Vincristin, Prednisolon (BOP) in der Therapie von fortgeschrittenen niedrig malignen Non-Hodgkin-Lymphomen. DMW - Deutsche Medizinische Wochenschrift. 126(8). 198–202. 6 indexed citations
14.
Kath, R., et al.. (2001). Bendamustine monotherapy in advanced and refractory chronic lymphocytic leukemia. Journal of Cancer Research and Clinical Oncology. 127(1). 48–54. 96 indexed citations
15.
Höffken, K. & R. Kath. (2000). Peptides in oncology III : somatostatin and LH-RH analogues. Springer eBooks. 1 indexed citations
16.
Kath, R., Michael Hartmann, & K. Höffken. (1998). Pharmacoeconomic evaluation of high-dose chemotherapy and peripheral blood stem cell support in high-risk or poor-prognosis malignancies. Journal of Cancer Research and Clinical Oncology. 124(5). 288–290. 5 indexed citations
17.
Höffken, K.. (1993). Peptides in oncology II : somatostatin analogues and bombesin antagonists. Springer eBooks. 2 indexed citations
18.
Kloke, Marianne, K. Höffken, H. G. Olbrich, & Christin Schmidt. (1991). Anti-Depressants and Anti-Convulsants for the Treatment of Neuropathic Pain Syndromes in Cancer Patients. Oncology Research and Treatment. 14(1). 40–43. 15 indexed citations
19.
Höffken, K., W. Jonat, K. Possinger, et al.. (1990). Aromatase inhibition with 4-hydroxyandrostenedione in the treatment of postmenopausal patients with advanced breast cancer: a phase II study.. Journal of Clinical Oncology. 8(5). 875–880. 69 indexed citations
20.
Melchner, Harald von & K. Höffken. (1984). T lymphocyte-mediated graft--antigraft reactivity during graft-versus- host reaction in vitro. Blood. 63(4). 812–817. 6 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Jon P. Gockerman Breakdown of academic impact, for papers by Peter F. Coccia Breakdown of academic impact, for papers by Marek Z. Wojtukiewicz Breakdown of academic impact, for papers by Donn C. Young Breakdown of academic impact, for papers by Séamus O’Reilly Breakdown of academic impact, for papers by Peter C. Huijgens Breakdown of academic impact, for papers by Gloria Broadwater Breakdown of academic impact, for papers by James A. Neidhart Breakdown of academic impact, for papers by Ann T. Farrell Breakdown of academic impact, for papers by Shouhao Zhou
Rankless by CCL
2026